$6.16
0.060.90%
At Close: -
$6.10
-0.06-0.89%
After Hours: Jul 2, 4:00 PM EDT
15 minutes delayed
Fulcrum Therapeutics
FULCNASDAQ
Fulcrum Therapeutics (NASDAQ:FULC) Stock, Earnings Estimates, EPS, And Revenue
Fulcrum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS
$-0.430
Quarterly Revenue
$0K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2.5M
Analyze the earnings history of Fulcrum Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics | -$0.38 | — | — | — | $880.00K | — | — | — | 08/01/2024 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.41 | -$0.44 | -$0.43 | 2.27% | $259.00K | $360.00K | $0.00 | -100.00% | 05/13/2024 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.50 | -$0.43 | -$0.40 | 6.98% | $685.00K | $460.00K | $871.00K | 89.35% | 02/27/2024 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.51 | -$0.44 | -$0.39 | 11.36% | $1.18M | $1.05M | $759.00K | -27.71% | 11/07/2023 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.83 | -$0.44 | -$0.38 | 13.64% | $1.88M | $1.60M | $880.00K | -45.00% | 08/03/2023 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.64 | -$0.46 | -$0.41 | 10.87% | $2.59M | $1.13M | $259.00K | -77.08% | 05/15/2023 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.58 | -$0.49 | -$0.50 | -2.04% | $5.06M | $1.65M | $685.00K | -58.48% | 03/09/2023 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.57 | -$0.62 | -$0.51 | 17.74% | $4.93M | $2.54M | $1.18M | -53.43% | 11/08/2022 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.60 | -$0.66 | -$0.83 | -25.76% | $4.38M | $2.96M | $1.88M | -36.42% | 08/11/2022 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.54 | -$0.63 | -$0.64 | -1.59% | $4.79M | $3.94M | $2.59M | -34.21% | 05/09/2022 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.64 | -$0.73 | -$0.58 | 20.55% | $4.22M | $2.68M | $5.06M | 88.73% | 03/03/2022 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.70 | -$0.65 | -$0.57 | 12.31% | $1.85M | $2.25M | $4.93M | 119.33% | 11/04/2021 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.66 | -$0.62 | -$0.60 | 3.23% | $2.00M | — | $4.38M | — | 08/10/2021 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.81 | -$0.66 | -$0.54 | 18.18% | $750.00K | $1.42M | $4.79M | 237.25% | 05/06/2021 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.71 | — | -$0.64 | — | $0.00 | $1.31M | $4.22M | 222.52% | 03/04/2021 | Get Alert |
| FULC | Fulcrum Therapeutics | -$0.97 | -$0.65 | -$0.70 | -7.69% | $0.00 | $550.00K | $1.85M | 236.00% | 11/10/2020 | Get Alert |
| FULC | Fulcrum Therapeutics | -$9.21 | -$0.78 | -$0.66 | 15.38% | $0.00 | — | $2.00M | — | 08/11/2020 | Get Alert |
| FULC | Fulcrum Therapeutics | — | -$0.75 | -$0.81 | -8.00% | — | — | $750.00K | — | 05/13/2020 | Get Alert |
| FULC | Fulcrum Therapeutics | -$7.82 | -$0.83 | -$0.71 | 14.46% | — | — | $0.00 | — | 03/05/2020 | Get Alert |
| FULC | Fulcrum Therapeutics | — | -$2.98 | -$0.97 | 67.45% | — | — | $0.00 | — | 11/14/2019 | Get Alert |
| FULC | Fulcrum Therapeutics | — | -$3.10 | -$9.21 | -197.10% | — | — | $0.00 | — | 08/26/2019 | Get Alert |
Fulcrum Therapeutics (FULC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-13 | $-0.43 | $-0.44 | 2.27 % |
| Dec 2023 | 2024-02-27 | $-0.40 | $-0.43 | 6.98 % |
| Sep 2023 | 2023-11-07 | $-0.39 | $-0.44 | 11.4 % |
| Jun 2023 | 2023-08-03 | $-0.38 | $-0.44 | 13.6 % |
Fulcrum Therapeutics (FULC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-13 | $0 | $360.00K | -100.0 % |
| Dec 2023 | 2024-02-27 | $871.00K | $460.00K | 89.3 % |
| Sep 2023 | 2023-11-07 | $759.00K | $1.05M | -27.7 % |
| Jun 2023 | 2023-08-03 | $880.00K | $1.60M | -45.0 % |
FAQ
When is Fulcrum Therapeutics (NASDAQ:FULC) reporting earnings?
Fulcrum Therapeutics (FULC) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 13, 2024 for Q1.
What were the latest earnings per share (EPS) for Fulcrum Therapeutics (NASDAQ:FULC)?
The Actual EPS was $-0.43, which beat the estimate of $-0.44.
What were Fulcrum Therapeutics’s (NASDAQ:FULC) revenues?
The Actual Revenue was $0K, which missed the estimate of $360K.
Browse earnings estimates, EPS, and revenue on all stocks.